XML 32 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
License and Collaborative Agreements (Details) (USD $)
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Licensing Agreements [Member]
University of Southern California [Member]
Jun. 30, 2013
Licensing Agreements [Member]
University of Southern California [Member]
Jun. 30, 2014
Licensing Agreements [Member]
University of Southern California [Member]
Jun. 30, 2013
Licensing Agreements [Member]
University of Southern California [Member]
Jun. 30, 2014
Licensing Agreements [Member]
Roche Molecular Systems [Member]
Jun. 30, 2013
Licensing Agreements [Member]
Roche Molecular Systems [Member]
Jun. 30, 2014
Licensing Agreements [Member]
Roche Molecular Systems [Member]
Jun. 30, 2013
Licensing Agreements [Member]
Roche Molecular Systems [Member]
Dec. 31, 2013
Licensing Agreements [Member]
Glaxo, Smith, Kline [Member]
May 31, 2013
Licensing Agreements [Member]
Glaxo, Smith, Kline [Member]
Jul. 31, 2012
Licensing Agreements [Member]
Glaxo, Smith, Kline [Member]
Jun. 30, 2014
Service Agreements [Member]
Glaxo, Smith, Kline [Member]
Jun. 30, 2013
Service Agreements [Member]
Glaxo, Smith, Kline [Member]
Jun. 30, 2014
Service Agreements [Member]
Glaxo, Smith, Kline [Member]
Jun. 30, 2013
Service Agreements [Member]
Glaxo, Smith, Kline [Member]
Jun. 30, 2014
Service Agreements [Member]
Taiho Pharmaceutical Co., Ltd. [Member]
Jun. 30, 2013
Service Agreements [Member]
Taiho Pharmaceutical Co., Ltd. [Member]
Jun. 30, 2014
Service Agreements [Member]
Taiho Pharmaceutical Co., Ltd. [Member]
Jun. 30, 2013
Service Agreements [Member]
Taiho Pharmaceutical Co., Ltd. [Member]
Jun. 30, 2014
Service Agreements [Member]
GlaxoSmithKline LLC [Member]
Jun. 30, 2014
Service Agreements [Member]
GSK Bio [Member]
Jun. 30, 2013
Service Agreements [Member]
GSK Bio [Member]
Jun. 30, 2014
Service Agreements [Member]
GSK Bio [Member]
Jun. 30, 2013
Service Agreements [Member]
GSK Bio [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                                                        
Royalty Expense         $ 10,449 $ 86,908 $ 21,410 $ 191,014 $ 113,704 $ 84,362 $ 158,077 $ 174,507                                
Revenue, Net, Total 4,281,235 5,313,914 8,176,169 10,938,105                       0 2,814 0 2,814 0 306,260 0 340,180 0 392,875 1,176,361 721,155 2,532,745
Revenue Recognition, Milestone Method, Revenue Recognized                         $ 500,000 $ 500,000 $ 500,000                          
Collaborative Agreement, Additional Period For Renewal                                   1 year [1]                    
Collaborative Agreement, Termination Notice Period                                                     90 days  
[1] Represents less than 10% of accounts receivable